Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
229.00    1.00 (0.44%)
Bid:
228.00
Ask:
229.00
Spread: 1.00 (0.439%)
Market Cap: £632.99m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

23 Apr 2010 07:00

RNS Number : 6572K
Morgan Crucible Co PLC
23 April 2010
 



Press Release

Interim Management Statement 

The Morgan Crucible Company plc

23rd April 2010

 

 

The Morgan Crucible Company plc ('Morgan Crucible'), the advanced materials company, is today holding its annual general meeting and issuing its 'Interim Management Statement' regarding trading and financial performance for the first quarter of 2010 and outlook for the full year 2010.

 

This statement constitutes Morgan Crucible's Interim Management Statement for the period from 4th January to 22nd April 2010 as required by the UK Listing Authority's Disclosure and Transparency Rules.

 

 

 

·; The Group has had an encouraging start to 2010. Overall we have seen trading conditions improve with steadily increasing levels of order intake since the fourth quarter of 2009.

 

·; Demand in Asia is robust, improving in most end markets in North America and stable in Europe.

 

·; Operating profits and margins are above the comparable period for 2009 and in line with management expectations, benefiting from the positive impact of cost savings made in 2009.

 

·; We continue to manage our cost base carefully so that the business will benefit fully from any operational leverage as revenues continue to recover.

 

 

 Commenting on the year to date performance and outlook, Mark Robertshaw, Chief Executive Officer, said:

 

"Whilst recognising that it is still early in the year, I am encouraged by the Group's trading so far in 2010. There are signs of end market demand improving in Asia and in North America with Europe showing stability. With the benefits of the cost reductions made last year coming through, we believe that Morgan Crucible is well placed to capitalise on market opportunities going forward.''

 

Carbon

 

In the first three months of 2010, our Carbon businesses, excluding NP Aerospace, have achieved good revenue increases compared with both the comparative period in 2009 and in particular against the last three months of 2009. Encouragingly we are seeing growth in all regions and across most product lines. The strongest revenue growth has been in China and, to a lesser extent, in the Americas, where we are benefiting from an improvement in the electrical and seal and bearing businesses. Europe is showing some revenue improvement but not to the same level as other regions. The steady improvement in order intake is giving increased confidence in the sustainability of this recovery across the breadth of our end markets. As expected and previously advised, whilst revenues in NP Aerospace are below those achieved in 2009, they remain in line with our expectations to deliver full year revenues of c£120 million. We have continued to expand our activities in the renewable energy sectors and we remain optimistic that our initiatives in solar, wind and energy storage hold promise for future growth.

 

 

Technical Ceramics

 

The opening quarter of 2010 has seen the majority of the Technical Ceramics division's markets continue to improve with order books increasing steadily.

 

Of particular note is the performance of the North American markets where there has been a general pickup in demand for a wide range of applications from aerospace to general industrial markets. We have, however, seen some weakness in the medical device markets where there has been a level of destocking - a situation which we expect to improve in the second half of the year. The production ramp-up for the new range of Hard Disc Drive products is progressing to plan. The European market is still lagging the US but there are improved levels of activity with new orders coming through particularly in thermal processing applications. Our Asian business, although smaller in scale, is reporting improved revenues from both construction and solar power markets. Revenue for industrial gas turbine products remains weak across the globe and the outlook in this market remains subdued. Work to consolidate our California plants is proceeding to plan and the anticipated benefits are coming through.

 

 

Thermal Ceramics

 

Since the beginning of the year, overall market conditions have improved for the Thermal Ceramics division though the situation varies both by region and end market. While the order intake for industrial insulation applications in Europe has shown little progression, the markets of North America and Latin America are gradually improving and our Asian businesses in general are achieving a clear strengthening of order volumes. More specifically, increasing revenue levels in India and China are encouraging. In other sectors, the same variations are apparent; the building sector in Europe has been doubly hit by the economic downturn and harsh winter that halted many construction projects, whilst chemical and petroleum markets, which had remained robust throughout the recession period, are now seeing further order improvements, notably from the Latin American market place. In iron and steel the emerging markets are exhibiting signs of a further period of expansion, though this sector remains subdued in mature western markets. 

 

 

Molten Metal Systems

 

Revenues in the Molten Metal Systems division have continued to improve with particularly good growth in Asia. Margins have benefited from the reduction in operating costs implemented in the first half of 2009. The new plant in Suzhou, China, and our expanded Indian operations have all increased output, enabling the business to capitalise on a lower cost base going forward.

 

 

Financial position

 

There was no material change in the financial position of the Group during the first quarter of 2010 except for the increase in its equity stake in NP Aerospace from 60% to 70% for a consideration of £27.2 million to be paid in two tranches; £14.8 million on 1st April 2010 and the balance in July 2010.

 

 

Outlook

 

Whilst we believe it is too early to talk about sustained long term recovery, our trading year to date and improving levels of order intake, currently leave us optimistic about our business outlook for the remainder of 2010.

 

 

 

For further enquiries:

 

Mark Robertshaw

Morgan Crucible

01753 837000

Kevin Dangerfield

 

 

 

 

 

Mike Smith / Clare Hunt

Finsbury

020 7251 3801

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUGDSUUDBGGD
Date   Source Headline
19th Sep 201610:52 amRNSDirector/PDMR Shareholding
13th Sep 201611:43 amRNSDirector/PDMR Shareholding
23rd Aug 20163:59 pmRNSHolding(s) in Company
28th Jul 201611:40 amRNSHolding(s) in Company
27th Jul 20167:00 amRNSHalf-Year Results
29th Jun 20161:19 pmRNSHolding(s) in Company
29th Jun 20161:16 pmRNSHolding(s) in Company - Amendment
22nd Jun 201611:59 amRNSHolding(s) in Company
20th Jun 201611:22 amRNS2015 Environmental, Health and Safety Report
15th Jun 201610:18 amRNSBlock listing Interim Review
31st May 20162:55 pmRNSDirector/PDMR Shareholding
24th May 201612:31 pmRNSDirector/PDMR Shareholding
6th May 20162:23 pmRNSResult of AGM
6th May 20167:00 amRNSTrading update
18th Apr 20162:39 pmRNSDirector/PDMR Shareholding
8th Apr 20167:00 amRNSAppointment of Non-Executive Director
7th Apr 20164:30 pmRNSDirector/PDMR Shareholding
6th Apr 20161:18 pmRNSAnnual Financial Report
5th Apr 20167:00 amRNSDirectorate Change
30th Mar 20167:00 amRNSAppointment of Chief Financial Officer
24th Mar 20167:00 amRNSBoard Change
24th Feb 20161:08 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSFinal Results
4th Feb 201610:56 amRNSDirectorate Change
1st Feb 20161:56 pmRNSDirector Declaration
22nd Jan 20167:00 amRNSAppointment of a Non-Executive Director
14th Jan 201612:33 pmRNSHolding(s) in Company
30th Dec 201510:10 amRNSDirector/PDMR Shareholding
18th Dec 20152:22 pmRNSDirector/PDMR Shareholding
16th Dec 20151:26 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
15th Dec 20153:56 pmRNSHolding(s) in Company
15th Dec 20153:16 pmRNSBlocklisting Interim Review
2nd Dec 20159:10 amRNSHolding(s) in Company
26th Nov 201512:22 pmRNSDirector/PDMR Shareholding
24th Nov 20153:25 pmRNSHolding(s) in Company
13th Nov 201512:18 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSTrading Update
9th Oct 201511:14 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSBoard Change
29th Sep 20152:47 pmRNSDirector/PDMR Shareholding
25th Sep 201510:43 amRNSDirector Declaration
17th Sep 201511:50 amRNSHolding(s) in Company
11th Sep 201511:23 amRNSHolding(s) in Company
10th Sep 20153:21 pmRNSHolding(s) in Company
2nd Sep 20159:11 amRNSDirector/PDMR Shareholding
20th Aug 201512:07 pmRNSDirector/PDMR Shareholding
4th Aug 201510:13 amRNSDirector/PDMR Shareholding
22nd Jul 20157:00 amRNSHalf Yearly Results
2nd Jul 20155:22 pmRNSHolding(s) in Company
15th Jun 20153:53 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.